Involvement of the Sodium Pump and Endogenous Digitalis-like Compounds in Bipolar Disorder (NA\K-MANIA)
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study deals with the possible molecular mechanisms that underlie the etiology of bipolar disorders (BD). Previous studies have implicated Na+, K+-ATPase and endogenous digitalis-like compounds (DLC) in the depressive state of this disease. The possibility, however, that they are also involved in the manic phase of the disease was never addressed. The results of this study may have significant implications for the treatment of BD by DLC derivatives.
| Condition |
|---|
|
BIPOLAR DISORDER |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Involvement of the Sodium Pump and Endogenous Digitalis-like Compounds in Bipolar Disorder |
30 cc of pperipheral blood will be taken every 4 months to determine circulating DLC levels in patients
| Estimated Enrollment: | 50 |
| Study Start Date: | May 2011 |
| Groups/Cohorts |
|---|
|
Na+, K+-ATPase/DLC system in BD
Bipolar patients in the various phases of the disease.
|
Detailed Description:
Depressive symptoms are the hallmark major depressive disorder, dysthymia and bipolar depression within the context of bipolar disorder (BD). They share clinical characteristics including depressed mood, anhedonia, and low energy and require medical treatment. The Na+, K+-ATPase is a major transporter in the plasma membrane which has an important role in regulating cell volume, cytoplasmic pH and Ca++ levels. Digitalis-like compounds (DLC); steroids identified as normal constituents of human brain, plasma and other tissues, exclusively interact with the Na+, K+-ATPase and induce numerous biological effects. We raised the hypothesis that Na+, K+-ATPase/DLC system is involved in BD based on studies from ours and other laboratories, which tested the involvement of this system in the depressive state of BD. The possibility that the interaction of DLC with the Na+, K+-ATPase is involved in the manic state of BD was scarcely investigated. To address this issue we intend to determine circulating DLC levels in patients with BD at different states of the disease;
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
ALL BIPOLAR PATIENTS IN THE HADASSAH MEDICAL ORGANIZATION PSYCHIATRIC OUTPATIENTS CLINIC
Inclusion Criteria:
- BIPOLAR DISORDER PATIENTS
Exclusion Criteria:
- NONE
Contacts and Locations| Contact: RENA COOPER-KAZAZ, DR | 00-972-2-6777348 | crena@hadassah.org.il |
| Contact: HADAS LAMBERG, pHD | 00-972-2-6777572 | lhadas@hadassah.org.il |
| Israel | |
| Hadassah Medical Organization | Recruiting |
| Jerusalem, Israel | |
| Contact: Rena Cooper-Kazaz, MD 00 972 2 6777184 crena@hadassah.org.il | |
| Principal Investigator: Rena Cooper-Kazaz, MD | |
| Principal Investigator: | RENA COOPER-KAZAZ, DR | Hadassah Medical Organization |
More Information
No publications provided
| Responsible Party: | DR RENA COOPER-KAZAZ, Hadassah Medical Organization |
| ClinicalTrials.gov Identifier: | NCT01322113 History of Changes |
| Other Study ID Numbers: | NA/K PUMP-MANIA-HMO-CTIL |
| Study First Received: | March 23, 2011 |
| Last Updated: | March 21, 2013 |
| Health Authority: | ISRAEL MINISTRY OF HEALTH DIRECTOR GENERAL, ISRAEL':' |
Keywords provided by Hadassah Medical Organization:
|
BIPOLAR MANIA DEPRESSION |
Additional relevant MeSH terms:
|
Bipolar Disorder Affective Disorders, Psychotic Mood Disorders Mental Disorders |
ClinicalTrials.gov processed this record on June 18, 2013